New contrast agent for heart ultrasound to detect shunts
Part of Heart & circulation clinical trials.
This trial tests a new contrast agent (ASI-02) compared to a standard saline solution for people who need a heart ultrasound to detect a right-to-left shunt. It may help provide clearer images so doctors can make a better diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor thinks you need an ultrasound of your heart using a special contrast to look for a right-to-left shunt.
- You are 18 years or older.
- Not pregnant or breastfeeding, and if you could become pregnant, you are using effective birth control for at least a month before the study.
- No allergy to polysorbate 80.
- No unstable heart conditions or other serious illnesses that would make the study drug risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a small, wearable device that measures how fluid flows through your shunt during daily activities and sleep. It aims to help doctors better understand shunt function without needing repeated scans or hospital visits.
This trial is testing a wearable thermal device that checks if your CSF shunt is working properly. It may help understand if your headaches are linked to shunt problems. The study involves using the device at home for 30 days and going to a few follow-up visits.
This trial tests a new contrast agent called NH002 that is given through an IV to help doctors see the heart more clearly during an ultrasound (echocardiogram). It may help people whose standard heart ultrasound did not provide clear images of the heart's left ventricle.
This trial studies a small implant (an “atrial shunt” device) to improve symptoms and heart function in people with chronic left heart failure that stays active despite standard medicines. It focuses on whether the implant is safe and can help you feel better and possibly breathe easier.
This trial tests a new device to help doctors safely enter the left side of your heart during a procedure called ablation. If you are already scheduled for an ablation or a combined ablation and left atrial appendage closure, this study may be an option.
This study tests a new way to measure heart pressure using an ultrasound, which may help doctors decide how to treat patients in intensive care. If successful, it could be used more widely in the future.
Hear when a new Right-To-Left Shunt trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.